Matches in SemOpenAlex for { <https://semopenalex.org/work/W2023355364> ?p ?o ?g. }
Showing items 1 to 81 of
81
with 100 items per page.
- W2023355364 endingPage "163" @default.
- W2023355364 startingPage "159" @default.
- W2023355364 abstract "Vitiligo is a frequent dyschromia, characterized by achromic macules that reflect the absence of melanocytes. The cause of this selective destruction seems to be due to an autoimmune phenomenon. Tacrolimus is an immunomodulator produced by Streptomyces tsukubaensis, whose topical use has been approved for atopic dermatitis. It has been tested in other dermatoses where immunological phenomena are involved.During the period from September 1, 2003 to April 30, 2004, an open study was carried out on 12 cases of vitiligo treated with topical tacrolimus 0.1 % twice a day. The degree of repigmentation was analyzed using digital photography at the initial visit, and at three and six months. The response in each case was taken into consideration, as well as the response by treated area. Possible adverse effects during the treatment period were also noted.50 % of the patients treated showed repigmentation with good (50 %-75 %) or excellent (> 75 %) improvement after 6 months. All of the patients with facial involvement achieved repigmentation of over 50 % in this location. Repigmentation in all cases took place homogeneously and centripetally, rather than in a perifollicular pattern. Repigmentation began before three months of treatment had elapsed in 10 patients, and after three months in the remaining two. We did not find any evidence of adverse effects except pruritus in the eyelid area in two patients during the first week of treatment.We believe that tacrolimus 0.1 % applied topically for a minimum of six months may be a valid alternative in the treatment of vitiligo in the facial area, especially the eyelids, where other therapeutic modes are not recommended because of the possible side effects." @default.
- W2023355364 created "2016-06-24" @default.
- W2023355364 creator A5025919584 @default.
- W2023355364 creator A5060997175 @default.
- W2023355364 creator A5075813520 @default.
- W2023355364 creator A5077297976 @default.
- W2023355364 creator A5086734594 @default.
- W2023355364 creator A5091491778 @default.
- W2023355364 date "2005-04-01" @default.
- W2023355364 modified "2023-09-24" @default.
- W2023355364 title "Vitíligo. Tratamiento de 12 casos con tacrolimus tópico" @default.
- W2023355364 cites W1966519690 @default.
- W2023355364 cites W1969332109 @default.
- W2023355364 cites W1984006272 @default.
- W2023355364 cites W1984833996 @default.
- W2023355364 cites W2013724612 @default.
- W2023355364 cites W2017735027 @default.
- W2023355364 cites W2023751867 @default.
- W2023355364 cites W2025876045 @default.
- W2023355364 cites W2056418327 @default.
- W2023355364 cites W2081697841 @default.
- W2023355364 cites W2086896236 @default.
- W2023355364 cites W2142040104 @default.
- W2023355364 cites W77302072 @default.
- W2023355364 doi "https://doi.org/10.1016/s0001-7310(05)73058-1" @default.
- W2023355364 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16476357" @default.
- W2023355364 hasPublicationYear "2005" @default.
- W2023355364 type Work @default.
- W2023355364 sameAs 2023355364 @default.
- W2023355364 citedByCount "10" @default.
- W2023355364 countsByYear W20233553642014 @default.
- W2023355364 countsByYear W20233553642016 @default.
- W2023355364 countsByYear W20233553642017 @default.
- W2023355364 countsByYear W20233553642019 @default.
- W2023355364 crossrefType "journal-article" @default.
- W2023355364 hasAuthorship W2023355364A5025919584 @default.
- W2023355364 hasAuthorship W2023355364A5060997175 @default.
- W2023355364 hasAuthorship W2023355364A5075813520 @default.
- W2023355364 hasAuthorship W2023355364A5077297976 @default.
- W2023355364 hasAuthorship W2023355364A5086734594 @default.
- W2023355364 hasAuthorship W2023355364A5091491778 @default.
- W2023355364 hasConcept C126322002 @default.
- W2023355364 hasConcept C141071460 @default.
- W2023355364 hasConcept C16005928 @default.
- W2023355364 hasConcept C197934379 @default.
- W2023355364 hasConcept C2779980618 @default.
- W2023355364 hasConcept C2781302119 @default.
- W2023355364 hasConcept C2909675724 @default.
- W2023355364 hasConcept C2911091166 @default.
- W2023355364 hasConcept C71924100 @default.
- W2023355364 hasConceptScore W2023355364C126322002 @default.
- W2023355364 hasConceptScore W2023355364C141071460 @default.
- W2023355364 hasConceptScore W2023355364C16005928 @default.
- W2023355364 hasConceptScore W2023355364C197934379 @default.
- W2023355364 hasConceptScore W2023355364C2779980618 @default.
- W2023355364 hasConceptScore W2023355364C2781302119 @default.
- W2023355364 hasConceptScore W2023355364C2909675724 @default.
- W2023355364 hasConceptScore W2023355364C2911091166 @default.
- W2023355364 hasConceptScore W2023355364C71924100 @default.
- W2023355364 hasIssue "3" @default.
- W2023355364 hasLocation W20233553641 @default.
- W2023355364 hasLocation W20233553642 @default.
- W2023355364 hasOpenAccess W2023355364 @default.
- W2023355364 hasPrimaryLocation W20233553641 @default.
- W2023355364 hasRelatedWork W1570781041 @default.
- W2023355364 hasRelatedWork W1981000424 @default.
- W2023355364 hasRelatedWork W2015336554 @default.
- W2023355364 hasRelatedWork W2017735027 @default.
- W2023355364 hasRelatedWork W2355754365 @default.
- W2023355364 hasRelatedWork W2383453488 @default.
- W2023355364 hasRelatedWork W2396722768 @default.
- W2023355364 hasRelatedWork W2943999970 @default.
- W2023355364 hasRelatedWork W90771098 @default.
- W2023355364 hasRelatedWork W2514601066 @default.
- W2023355364 hasVolume "96" @default.
- W2023355364 isParatext "false" @default.
- W2023355364 isRetracted "false" @default.
- W2023355364 magId "2023355364" @default.
- W2023355364 workType "article" @default.